|
National Stock Number(NSN): 6505-01-310-1689 (6505013101689, 013101689)
| NIIN: |
01-310-1689 |
Item Name: |
CEFOTAXIME SODIUM |
INC: |
66662
|
| FSC: |
6505
|
Assignment Date: |
Oct-31-1989 |
CRIT: |
X |
IIG: |
66662 |
| ISC: |
2 |
Date Standardized: |
Oct-31-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2014 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9185 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0923 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CLAFORAN |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CLAFORAN IN ADD-VANTAGE VIALS |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00039-0023-50 |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
M |
U |
1 |
A |
$1,562.67 |
PG |
|
C2201X- |
May-01-2014 |
H |
| DF |
SMS |
Y |
|
M |
U |
1 |
F |
$1,562.67 |
PG |
|
------- |
May-01-2014 |
H |
| DM |
SMS |
Y |
Z |
M |
U |
1 |
M |
$1,562.67 |
PG |
|
13B2--1 |
May-01-2014 |
H |
| DN |
SMS |
Y |
|
M |
U |
1 |
N |
$1,562.67 |
PG |
|
9B----- |
May-01-2014 |
H |
| DS |
SMS |
Y |
N |
M |
U |
1 |
D |
$1,562.67 |
PG |
|
------- |
May-01-2014 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 50EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 50EA |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 50EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 50EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 50EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 GRAMS CEFOTAXIME EQUIVALENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
50 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
CEFOTAXIME SODIUM STERILE USP 1GM VIAL 50S |
| FEAT |
SPECIAL FEATURES |
15ML GLASS VIAL HAVING A DOUBLE LEAD THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS; 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242 AND 6505-01-260-6715; EACH VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER SHROUD |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A911 |
A111 |
Dec-01-2006 |
3 |
Z |
|
|
AM|GX |
AM|BN|GX |
| FSGM |
FSKX |
Dec-01-2006 |
3 |
Z |
|
|
GX|TT |
GX|SS|TT |
| MC55 |
MC15 |
Dec-01-2006 |
3 |
Z |
|
|
GX|PA |
GX|PA |
| N9BL |
N9LM |
Dec-01-2006 |
3 |
Z |
|
|
GX |
GH|GX |
| Source: |
P |
Primary Inventory Control Activity (PICA) |
Status: |
H |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
ZZZZ |
| Lvl A Pkg Req: |
Z |
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
|
Unit Pack Weight: |
0.0 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.000 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
M |
Unpkg Item Dims: |
|
Spec Marking: |
ZZ |
| Container FSC: |
|
SPI Number: |
MPPWN00001 |
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
Mar-30-1988 |
Pkg Design Activity: |
89875
|
| Inter Container Qty: |
|
Inter Container Code: |
|
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
|
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|